Skip to content

CapEx at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$347M+33.5%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$133.4M+228%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$215K-60.6%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$769K+0.4%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$2.23M-27.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$69K

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's capex?
Disc Medicine (IRON) reported capex of $0 in Q1 2026.
How has Disc Medicine's capex changed year-over-year?
Disc Medicine's capex decreased by 100.0% year-over-year, from $851K to $0.
What is the long-term trend for Disc Medicine's capex?
Over 2 years (2022 to 2025), Disc Medicine's capex has grown at a 148.6% compound annual growth rate (CAGR), from $151K to $933K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.